MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs

    S. Horn, E. Vaou, A. Parab, S. Wang, X. Pan, C. Yan, M. Shah, J. Jimenez-Shahed (San Antonio, USA)

    Objective: To compare neuropsychiatric disorders (NPsy), other non-motor symptoms (NMS), and associated medication use and costs in individuals with advanced Parkinson’s Disease (aPD) with those…
  • 2025 International Congress

    The influence of Caffeine intake on Type 2 Diabetes Mellitus mediated risk of Parkinson’s Disease.

    K. Mallavarapu, E. Tan (Singapore, Singapore)

    Objective: The objectives are to investigate if a diagnosis of Type 2 Diabetes Mellitus (T2DM) is associated with increased risk of developing Parkinson's Disease (PD)…
  • 2025 International Congress

    Deferiprone improves striatal dopamine by reducing neuroinflammation and oxidative stress in MPTP-induced mice model of Parkinson’s disease

    HSA. Olasore, JO. Faleti (Lagos, Nigeria)

    Objective: This study aimed to investigate the effect of deferiprone on the striatal DA, oxidative stress and neuroinflammation markers as well as motor deficits in…
  • 2025 International Congress

    Rescuing alpha-synuclein toxicity through neuron-specific enhancement of autophagy

    J. Chua, M. Farah, S. Tewari, A. Parvataneni, V. Dawson, T. Dawson (Baltimore, USA)

    Objective: In the present study, we aim to counteract regulatory and transcriptional modifiers of autophagy to enhance neuroprotective proteostasis and rescue alpha-synuclein (asyn) toxicity in…
  • 2025 International Congress

    Mathematical and Computational Modeling Prototype to Understand the Evolution of Parkinson’s disease using Four Differential Equations

    G. Sa, A. Rodrigues Tavares, M. Silva Bissaco (Mogi das Cruzes, Brazil)

    Objective: Apply four differential equations to generate projections considering the effect of dopamine on Parkinson’s disease progression, leading to the development of an initial prototype…
  • 2025 International Congress

    Comparison of MIBG Uptake in the Major Salivary Glands Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

    J. Ebina, S. Mizumura, M. Shibukawa, J. Nagasawa, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: This study aimed to evaluate 123I-metaiodobenzylguanidine (MIBG) uptake in the major salivary glands (MSG) in patients with rapid eye movement sleep behavior disorder (RBD)…
  • 2025 International Congress

    Multiparametric Prediction of Mild Cognitive Impairment in Parkinson’s Disease Using a Combination of Structural and Functional MRI Measures

    G. Rathi, T. Davis, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)

    Objective: To investigate whether the multiparametric combination of structural and functional (fMRI) neuroimaging parameters improves the prediction of mild cognitive impairment (MCI) in Parkinson's disease…
  • 2025 International Congress

    Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease

    J. Qin, M. Zhang (Hangzhou, China)

    Objective: This study aims to investigate whether single-nucleotide polymorphisms (SNPs) of the Aquaporin-4(AQP4) gene were related to abnormal protein accumulation (α-synuclein), glymphatic dysfunction (DTI-ALPS), and…
  • 2025 International Congress

    Whole Genome Sequencing of an Early-onset Malaysian Parkinson’s Disease Cohort

    YW. Tay, TS. Toh, JW. Hor, JL. Lim, KA. Ibrahim, AS. Mawardi, TT. Lim, I. Looi, YK. Chia, JCE. Ooi, WC. Law, J. Wong, YH. Lau, PC. Teh, TL. Ong, WK. Cheah, LC. Lit, KA. Muthusamy, L. Lange, KL. Lohmann, ZH. Fang, CK. Klein, AA. Ahmad-Annuar, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the genetic causes of Malaysian early-onset Parkinson’s disease (EOPD) patients with whole genome sequencing (WGS). Background: EOPD (age of diagnosis ≤50 years)…
  • 2025 International Congress

    Familial parkinson disease A comparative study between LRRK2 and PINK 1 mutations

    A. Mousli, R. Zouari, Z. Saeid, F. Nabli, A. Rachdi, D. Ben Mohamed, S. Ben Sassi (Tunis, Tunisia)

    Objective: Describe the clinical phenotypes of monogenic forms of PD linked to LRRK2 and PINK1 mutations with a view to a comparative study between the…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley